Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Boehringer Ingelheim
Harvard Business School
Moodys
Johnson and Johnson

Last Updated: May 17, 2022

CLINICAL TRIALS PROFILE FOR COLCHICINE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Colchicine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn National Heart, Lung, and Blood Institute (NHLBI) Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00000577 ↗ Asthma Clinical Research Network (ACRN) Withdrawn Milton S. Hershey Medical Center Phase 3 1993-09-01 This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
NCT00004368 ↗ Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis Unknown status Children's Hospital Colorado Phase 1 1990-05-01 OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
NCT00004368 ↗ Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis Unknown status National Center for Research Resources (NCRR) Phase 1 1990-05-01 OBJECTIVES: I. Investigate the efficacy and safety of colchicine therapy in improving hepatic function and reducing hepatic fibrosis (scarring) in children with hepatic cirrhosis.
NCT00004748 ↗ Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis Completed Tufts Medical Center Phase 3 1989-11-01 OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production.
NCT00004748 ↗ Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis Completed National Center for Research Resources (NCRR) Phase 3 1989-11-01 OBJECTIVES: I. Compare the efficacy of low-dose oral pulse methotrexate (MTX) and ursodiol versus colchicine and ursodiol in patients with primary biliary cirrhosis (PBC). II. Determine the optimum dose and duration of MTX treatment. III. Investigate the role of fibrogenic cytokines (FC) in PBC pathogenesis and the effect of treatment on FC production.
NCT00047489 ↗ Study of ABT-751 in Patients With Refractory Hematologic Malignancies Completed M.D. Anderson Cancer Center Phase 1 2002-12-01 ABT-751 is a new antitumor drug that that interferes with cell division. The goal of this clinical research study is to find the highest safe dose of ABT-751 that can be given as a treatment for refractory hematologic malignancies. The safety and side effects of ABT-751 will also be studied.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Colchicine

Condition Name

Condition Name for Colchicine
Intervention Trials
Gout 24
Pharmacokinetics 13
Atrial Fibrillation 11
COVID-19 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Colchicine
Intervention Trials
COVID-19 29
Gout 28
Inflammation 18
Atrial Fibrillation 15
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Colchicine

Trials by Country

Trials by Country for Colchicine
Location Trials
United States 401
Canada 37
Italy 26
China 20
Spain 17
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Colchicine
Location Trials
California 26
New York 23
Florida 20
Texas 18
North Dakota 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Colchicine

Clinical Trial Phase

Clinical Trial Phase for Colchicine
Clinical Trial Phase Trials
Phase 4 37
Phase 3 54
Phase 2/Phase 3 12
[disabled in preview] 112
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Colchicine
Clinical Trial Phase Trials
Completed 100
Recruiting 48
Unknown status 22
[disabled in preview] 42
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Colchicine

Sponsor Name

Sponsor Name for Colchicine
Sponsor Trials
Mutual Pharmaceutical Company, Inc. 20
Population Health Research Institute 9
Takeda 8
[disabled in preview] 27
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Colchicine
Sponsor Trials
Other 270
Industry 72
NIH 16
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Moodys
Mallinckrodt
Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.